Trial intelligence / Profile preview

Tiotropium plus salbutamol versus salbutamol in acute COPD exacerbation

2006-005819-10Phase 4Terminated

Sponsor
Philipps-Universität Marburg
Start
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in chronic obstructive pulmonary disease (COPD) comparing Tiotropium bromide plus salbutamol with Salbutamol alone (2 arms). Primary endpoint: MUC5AC response. Started Oct 2007; status: terminated.

02

Drugs

tiotropiumsalbutamol
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on 2006-005819-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005819-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call